Riskpilot← Back to searchSign inGet full accessClinvvo AB
ABActiveOrg 5592048838Idungränd 8Medical specialists activities · NACE 8622Est. 20191-4 employees
Revenue 2025
SEK 945K
+102% vs 2024
EBITDA margin
101.6%
+809% vs 2024
Equity ratio
13.0%
Financial strength
Net profit 2025
SEK 60K
+108% vs 2024
| Revenue | SEK 945K | +102% |
| EBITDA | SEK 960K | +809% |
| Net profit | SEK 60K | +108% |
| Total assets | SEK 2,8M | +5% |
| Equity | SEK 362K | +20% |
| Employees | — | — |
Legal name
Clinvvo AB
Org number
5592048838
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
8 maj 2019
Share capital
SEK 54 054
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska verka inom rådgivning, bokning och förmedling av sjukvård och hälsa samt bedriva verksamhet inom utveckling av teknologi- och applikationsportföljer samt därmed förenlig verksamhet.
Address
Idungränd 8
Email
hanneslewne@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 1 | 58 | 67 | 468 | 945 |
| Staff expenses | — | — | −51 | −0 | — |
| EBITDA | 14 | −261 | −436 | 106 | 960 |
| Depreciation & amort. | −22 | −73 | −275 | −615 | −691 |
| EBIT | −8 | −333 | −711 | −510 | 269 |
| Net financials | −27 | −37 | −161 | −223 | −209 |
| Profit before tax | −36 | −370 | −872 | −733 | 60 |
| Tax | −0 | — | — | — | — |
| Net profit | −36 | −370 | −872 | −733 | 60 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 706 | 3 517 | 3 509 | 2 650 | 2 785 |
| Equity | 27 | 1 903 | 1 035 | 302 | 362 |
| Long-term debt | 621 | 1 444 | 2 383 | 2 114 | 1 459 |
| Short-term debt | 58 | 170 | 92 | 234 | 964 |
| Total debt | 679 | 1 614 | 2 475 | 2 348 | 2 423 |
EBITDA margin
101.6%
This company
15.8%
Market median
+543% vs market
20212025
Equity ratio
13.0%
This company
38.2%
Market median
-66% vs market
20212025
Return on equity
16.6%
This company
18.4%
Market median
+10% vs market
20212025
Net profit margin
6.4%
This company
8.1%
Market median
-21% vs market
20212025
Asset turnover
0.34×
This company
1.12×
Market median
-70% vs market
20212025
Debt / equity
6.70×
This company
0.62×
Market median
-981% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-04-01 – 2025-03-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-04-01 – 2024-03-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-04-01 – 2023-03-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-04-01 – 2022-03-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-04-01 – 2021-03-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2020 | |
| Chairman | 2020 | |
| Board of Directors | 2022 | |
| Former (1) | ||
| Board of Directors | 2020 – 2025 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Clinvvo AB (this company)
Prev. India Private LimitedPREV. INDIA PRIVATE LIMITEDBoard members of Clinvvo AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eva Lisa Josefin Lewné | Board of Directors | 0 companies |
| Olle Andreasson | Board of Directors | 0 companies |
| Hannes Lennart Yngve Lewné | Chairman | 0 companies |
| Gaurav Dixit | Board of Directors | 0 companies |